🇺🇸 FDA
Patent

US 12156893

Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto

granted A61KA61K2035/115A61K2239/31

Quick answer

US patent 12156893 (Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto) held by The Regents of the University of California expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2035/115, A61K2239/31, A61K2239/38, A61K2239/54